Propanc Biopharma, Inc. (PPCB) 追蹤本益比為負值 0.0, 表示公司目前在過去十二個月 (TTM) 基礎上處於虧損狀態。 追蹤盈利收益率為 -4,483.27%.
本頁證實的標準:
SharesGrow 綜合評分： 25/100 其中 0/7 項標準通過。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -19,357,778,163.5 | 0.00 | -71,008,143,131.76 | 0.00 | - |
| 2017 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2018 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2019 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2020 | 0.0 | 0.00 | -0.05 | 0.00 | - |
| 2021 | -0.2 | 0.00 | -0.10 | 0.00 | - |
| 2022 | 0.0 | 0.00 | 0.00 | 0.00 | - |
| 2023 | -0.3 | 0.00 | -0.26 | 0.00 | - |
| 2024 | -0.1 | 0.00 | -0.03 | 0.00 | - |
| 2025 | -0.3 | 0.00 | 1.18 | 0.00 | - |
| Year | EPS（稀釋） | 營收 | 淨利潤 | 淨利潤率 |
|---|---|---|---|---|
| 2016 | $-0.24 | $0.00 | $-9.41M | - |
| 2017 | $-1,120,730,000.00 | $0.00 | $-7.87M | - |
| 2018 | $-178,749,000.00 | $0.00 | $-7.04M | - |
| 2019 | $-10,969,600.00 | $0.00 | $-5.76M | - |
| 2020 | $-192,449.00 | $0.00 | $-4.74M | - |
| 2021 | $-800.00 | $0.00 | $-2.03M | - |
| 2022 | $-1,119,480.00 | $0.00 | $-2.66M | - |
| 2023 | $-31,268.40 | $0.00 | $-2.66M | - |
| 2024 | $-1,200.00 | $0.00 | $-1.82M | - |
| 2025 | $-14.85 | $0.00 | $-58.92M | - |
